1-deoxynojirimycin has been researched along with zidovudine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aspinall, RL; Collier, AC; Coombs, R; Fass, RJ; Fife, KH; Fischl, MA; Kremer, AB; Pottage, JC; Powderly, WG; Resnick, L | 1 |
Charneau, P; Clavel, F | 1 |
Ratner, L; Vander Heyden, N | 1 |
1 trial(s) available for 1-deoxynojirimycin and zidovudine
Article | Year |
---|---|
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.
Topics: 1-Deoxynojirimycin; Adult; Antiviral Agents; beta 2-Microglobulin; CD4-Positive T-Lymphocytes; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Hemoglobins; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Neutrophils; Paresthesia; RNA, Viral; Zidovudine | 1994 |
3 other study(ies) available for 1-deoxynojirimycin and zidovudine
Article | Year |
---|---|
Several new AIDS drugs being tested.
Topics: 1-Deoxynojirimycin; Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; CD4 Antigens; Drug Therapy, Combination; Glucosamine; Humans; Interferon Type I; Sarcoma, Kaposi; Zalcitabine; Zidovudine | 1989 |
Fusion from without directed by human immunodeficiency virus particles.
Topics: 1-Deoxynojirimycin; CD4 Antigens; Cell Fusion; Cytopathogenic Effect, Viral; Genes, Reporter; HeLa Cells; HIV Envelope Protein gp120; HIV-1; Humans; Virus Replication; Zidovudine | 1994 |
Mechanism of action of N-butyl deoxynojirimycin in inhibiting HIV-1 infection and activity in combination with nucleoside analogs.
Topics: 1-Deoxynojirimycin; Antiviral Agents; CD4 Antigens; Cell Line; Didanosine; Drug Interactions; HIV Envelope Protein gp120; HIV-1; Humans; Nucleosides; Zalcitabine; Zidovudine | 1993 |